Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Remix Therapeutics to Participate in Upcoming Investor Conferences | ||
By: PR Newswire Association LLC. - 07 Feb 2024 | Back to overview list |
|
WATERTOWN, Mass., Feb. 7, 2024 /PRNewswire/ -- Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address underlying drivers of disease, today announced that management will participate in several upcoming investor conferences:
The Remix management team will be hosting one-on-one meetings with investors at each conference. For those investors interested in scheduling a meeting with the Remix team, please contact your Oppenheimer, Evercore ISI or TD Cowen representative. About Remix Therapeutics View original content to download multimedia:https://www.prnewswire.com/news-releases/remix-therapeutics-to-participate-in-upcoming-investor-conferences-302055324.html SOURCE Remix Therapeutics |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |